Viking Therapeutics (VKTX) Change in Account Payables: 2014-2025
Historic Change in Account Payables for Viking Therapeutics (VKTX) over the last 12 years, with Sep 2025 value amounting to -$1.1 million.
- Viking Therapeutics' Change in Account Payables rose 90.02% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 176.25%. This contributed to the annual value of $2.3 million for FY2024, which is 326.23% up from last year.
- Per Viking Therapeutics' latest filing, its Change in Account Payables stood at -$1.1 million for Q3 2025, which was up 51.06% from -$2.2 million recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Change in Account Payables ranged from a high of $9.6 million in Q4 2024 and a low of -$10.8 million during Q3 2024.
- Over the past 3 years, Viking Therapeutics' median Change in Account Payables value was -$1.1 million (recorded in 2025), while the average stood at -$374,091.
- Per our database at Business Quant, Viking Therapeutics' Change in Account Payables spiked by 563.74% in 2022 and then plummeted by 10,935.00% in 2024.
- Viking Therapeutics' Change in Account Payables (Quarterly) stood at -$1.4 million in 2021, then spiked by 487.55% to $5.4 million in 2022, then slumped by 66.57% to $1.8 million in 2023, then spiked by 430.87% to $9.6 million in 2024, then surged by 90.02% to -$1.1 million in 2025.
- Its Change in Account Payables was -$1.1 million in Q3 2025, compared to -$2.2 million in Q2 2025 and -$2.1 million in Q1 2025.